WallStreetZenWallStreetZen

NYSE: NVO
Novo Nordisk A S Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for NVO

Based on 1 analyst offering 12 month price targets for Novo Nordisk A S.
Min Forecast
$15.50-83.02%
Avg Forecast
$15.50-83.02%
Max Forecast
$15.50-83.02%

Should I buy or sell NVO stock?

Based on 1 analyst offering ratings for Novo Nordisk A S.
Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their NVO stock forecasts and price targets.

NVO stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
BTIG
Bottom 11%
11
Strong BuyMaintains$15.50-83.02%2023-03-28

1 of 1

Forecast return on equity

Is NVO forecast to generate an efficient return?
Company
N/A
Industry
0.91%
Market
28.82%

Forecast return on assets

Is NVO forecast to generate an efficient return on assets?
Company
N/A
Industry
0.07%

NVO earnings growth forecast

How is NVO forecast to perform vs Biotechnology companies and vs the US market?
Company
8.08%
Industry
7.6%
Market
20.23%
NVO's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
NVO's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
NVO's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

NVO revenue growth forecast

How is NVO forecast to perform vs Biotechnology companies and vs the US market?
Company
5.02%
Industry
35.95%
Market
8.15%
NVO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
NVO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

NVO vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
NVO$91.30$15.50-83.02%Strong Buy
VRTX$349.53$372.64+6.61%Strong Buy
REGN$824.84$908.17+10.10%Strong Buy
SGEN$213.70$229.00+7.16%Hold
MRNA$99.99$142.33+42.35%Buy
View Top Biotech Stocks

Novo Nordisk A S Stock Forecast FAQ

Is Novo Nordisk A S Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NYSE: NVO) stock is to Strong Buy NVO stock.

Out of 1 analyst, 1 (100%) are recommending NVO as a Strong Buy, 0 (0%) are recommending NVO as a Buy, 0 (0%) are recommending NVO as a Hold, 0 (0%) are recommending NVO as a Sell, and 0 (0%) are recommending NVO as a Strong Sell.

If you're new to stock investing, here's how to buy Novo Nordisk A S stock.

What is NVO's forecast return on equity (ROE) for 2023-2026?

(NYSE: NVO) forecast ROE is N/A, which is considered weak.

What is NVO's Price Target?

According to 1 Wall Street analyst that have issued a 1 year NVO price target, the average NVO price target is $15.50, with the highest NVO stock price forecast at $15.50 and the lowest NVO stock price forecast at $15.50.

The Wall Street analyst predicted that Novo Nordisk A S's share price could fall to $15.50 by Mar 28, 2024. The average Novo Nordisk A S stock price prediction forecasts a potential downside of 83.02% from the current NVO share price of $91.30.

What is NVO's forecast return on assets (ROA) for 2023-2026?

(NYSE: NVO) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 0.07%.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.